MedTrace raises $19M for its PET-boosting technology
MedTrace Pharma has raised €18.2 million to complete the Phase 3 trial of its tech to make PET with oxygen-15 labeled water widely available.
Stay updated with breaking news from Medtrace Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MedTrace Pharma has raised €18.2 million to complete the Phase 3 trial of its tech to make PET with oxygen-15 labeled water widely available.
N.B. This is an unofficial translation of the Swedish original wording. In case of differences between the English translation and the Swedish original, the Swedish text shall... | March 23, 2023
XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL) (FRA:3XV) XVIVO Perfusion AB (publ) (the "Company"), reg. no. 556561-0424, with its registered office in Gothenburg, gives notice of the the Annual General Meeting to be held on Tuesday 25 April 2023...
Notice to attend the Annual General Meeting in XVIVO Perfusion AB (publ) ...
GOTHENBURG, SE / ACCESSWIRE / March 23, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL) (FRA:3XV) XVIVO Perfusion AB (publ) (the "Company"), reg. no. 556561-0424, with its registered office in Gothenburg